Abstract: A computer-implemented method, a computer program and a system for optimising measurement processes are disclosed. The method, computer program and system comprise receiving one or more parameters for configuring a plurality of measurement processes, receiving one or more results, generating a predictor, determining updated parameters using the predictor, receiving one or more further results, generating an updated predictor and determining one or more enhanced parameters.

Abstract: A sensor device comprising one or more sensors configured to measure data, a controller and memory. The controller comprises an arithmetic-logic unit “ALU”. The controller is configured to cause the ALU to carry out computations for implementing an artificial neural network “ANN” comprising a network of interconnected nodes. The memory is coupled to the ALU, and is configured to store integers representing weights associated with interconnects between the nodes. The controller is operable to implement the ANN to: receive data measured by the one or more sensors; and determine a classification of the data based on the network of interconnected nodes and the weights associated with the interconnects.

Abstract: A method is disclosed herein for detecting an amplification reaction in a solution containing a biological sample using an array of ion sensors. The amplification reaction is indicative of the presence of a nucleic acid. The method comprises monitoring a signal from each respective sensor of the array of ion sensors, detecting a change in the signal from a first sensor of the array of ion sensors, and comparing the signal from the first sensor with the signal of at least one neighbouring sensor, the at least one neighbouring sensor being proximate to the first sensor in the array. The method further comprises determining, based on the comparing, that an amplification event has occurred in the solution in the vicinity of the first sensor.

Abstract: The present application relates to methods for detecting a tandem repeat in a nucleic acid sequence under isothermal conditions using primers.

Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.

Abstract: A method of manufacturing a metal fabric or membrane, the method comprises providing an ink comprising a plurality of semiconductor particles disposed in a first solvent. The method comprises applying the ink to a fabric or membrane to obtain a fabric or membrane comprising a plurality of semiconductor particles. Finally, the method comprises contacting the fabric or membrane comprising the plurality of semiconductor particles with a deposition solution comprising a second solvent, an autocatalytic agent, and metal cations to thereby cause a reaction to occur such that the metal cations are reduced and at least partially displace the semiconductor particles, to thereby provide a metal fabric or membrane.

Abstract: The invention relates to gene drives, and in particular to genetic sequences and constructs for use in a gene drive. The invention is especially concerned with ultra-conserved and ultra-constrained sequences for use as a gene drive target with the aim of overcoming the development of resistance to the drive. The invention is also concerned with methods of suppressing wild type arthropod populations by use of the gene drive construct described herein.

Abstract: The invention relates to Clostridioides difficile, and in particular to compounds, polypeptides and mixtures for the treatment of C. difficile infections. The invention also relates to nucleic acids, vectors comprising these nucleic acids and microorganisms for the treatment of C. difficile infections, and to methods of identifying and matching faecal microbiota transplant (FMT) donors to FMT recipients.

Abstract: Embodiments of the present disclosure are configured to assess the severity of a blockage in a vessel and, in particular, a stenosis in a blood vessel. In some particular embodiments, the devices, systems, and methods of the present disclosure are configured to assess the severity of a stenosis in the coronary arteries without the administration of a hyperemic agent.

Abstract: The invention relates to the treatment of a wound, and in particular to uses of polypeptides (or genetic constructs or vectors encoding such peptides) to promote wound healing and/or reduce, prevent or inhibit scarring. The invention extends to pharmaceutical compositions comprising such polypeptides or constructs, for treating wounds, and for reducing scarring, and cosmetic formulations for improving the appearance of skin. The invention also extends to wound dressings, formulations and bandages comprising such polypeptides.

Abstract: An aerial device (100) capable of controlled flight has a body (110), a rotor (120) arranged to rotate relative to the body; and a deployable sheet (130), the sheet having an undeployed configuration in which the sheet is folded against the body and a deployed configuration in which the sheet is at least partially unfolded away from the body.

Abstract: The present invention provides method for predicting risk of cervical shortening, methods for predicting risk of preterm labour (PTL), and methods for characterising a pregnant subject having a history of previous PTL, mid-trimester loss or cervical cone biopsy as being in need of surveillance and/or intervention to prevent preterm labour, comprising determining the expression level of one or more of the miRNA molecules identified in Table 1 or Table 2 extracted from a biological sample obtained from said subject and comparing to a control value. Biochips and kits for use in carrying out the methods of the invention are also provided.

Abstract: Examples described herein relate to mapping a space using a multi-directional camera. This mapping may be performed with a robotic device comprising a monocular multi-directional camera device and at least one movement actuator. The mapping may generate an occupancy map to determine navigable portions of the space. A robotic device movement around a point in a plane of movement may be instructed using the at least one movement actuator. Using the monocular multi-directional camera device, a sequence of images are obtained (610) at different angular positions during the instructed movement. Pose data is determined (620) from the sequence of images. The pose data is determined using features detected within the sequence of images. Depth values are then estimated (630) by evaluating a volumetric function of the sequence of images and the pose data. The depth values are processed (640) to populate the occupancy map for the space.

Abstract: Apparatus and method establish quantum oscillations at room temperature. A cavity has therein a resonator structure that includes a resonant element and a gain medium. A species of the gain medium has an electronic spin multiplicity capable of supporting a two-level spin system. An optical pump pumps the resonator structure and thereby generates microwave output power through stimulated emission of thermal photons. The species of the gain medium is of a sufficiently high concentration such as to have an ensemble spin-photon coupling rate which exceeds both the cavity mode decay rate and the spin-spin decoherence rate. The optical pump pumps the resonator structure using a short pulse of nanosecond duration, or a burst of approximately a millisecond in duration at relatively low instantaneous optical power, to excite said species of the gain medium into a spin-polarized two-level system that exhibits quantum oscillations in the microwave output power.

Abstract: The present invention provides method for predicting risk of cervical shortening, methods for predicting risk of preterm labour (PTL), and methods for characterising a pregnant subject having a history of previous PTL, mid-trimester loss or cervical cone biopsy as being in need of surveillance and/or intervention to prevent preterm labour, comprising determining the expression level of one or more of the miRNA molecules identified in Table 1 or Table 2 extracted from a biological sample obtained from said subject and comparing to a control value. Biochips and kits for use in carrying out the methods of the invention are also provided.

Abstract: The present invention relates to a system and method useful for determining the voltage of biological tissues and therefore to detect whether such tissues are cancerous.

Abstract: An apparatus and method of assessing a narrowing in a fluid filled tube having a fluid flow pressure wave having a backward-originating pressure component and a forward-originating pressure component without taking a flow velocity measurement, comprising: taking pressure measurements in the tube; separating the pressure components into the backward-originating pressure component and the forward-originating pressure component; identifying a time window when the differential of flow velocity (dU) is minimal or absent; and deriving the backward and forward pressure components for pressure measurements taken in at least the time window.

Abstract: The invention relates to an MRI apparatus and a method of MRI involving the acquisition of a first and a second MRI image with mutually different orientations between the BO magnetic field and the object to be investigated. For instance, when imaging structures such as a tendon, due to the magic angle effect, this results in a change in image contrast. According to the invention, a coregistration can be performed between the first and the second MRI image. Moreover, the orientation of a structure within the object can be determined on the basis of the different orientations and the image intensity in the first and the second MRI image. The invention further discloses an apparatus for carrying out the method and a method of shimming the BO magnetic field of the apparatus.

Abstract: This invention relates to Natural Killer (NK) cell populations, to methods of producing the same and therapeutic applications thereof. More specifically, the invention relates to the expansion of NK cells by increasing the expression of specific transcription factors associated with NK cell production.

Abstract: The present invention is directed to a method for detecting the presence or absence of a bacterium resistant to a cyclic cationic polypeptide antibiotic, comprising: (a) subjecting a test sample to mass spectrometry analysis and generating a mass spectrum output; wherein said test sample comprises a bacterial membrane or a fragment thereof, wherein the fragment comprises a non-Lipid A component; (b) identifying in said mass spectrum output a first defined peak indicative of the presence of Lipid A modified by phosphoethanolamine, wherein said first defined peak is a peak present in a mass spectrum output for Lipid A modified by phospho-ethanolamine and wherein said first defined peak is absent from a corresponding mass spectrum output for native Lipid A; and (c) wherein the presence of said first defined peak indicates the presence of a bacterium resistant to a cyclic cationic polypeptide antibiotic, and wherein the absence of said first defined peak indicates the absence of a bacterium resistant to a cyclic